From Bloomberg News | Abbott Laboratories’ Humira spurred resistance in more than a quarter of patients taking the rheumatoid arthritis drug in a study, a finding that may weaken demand for the company’s top-selling medicine. Get the full story>>

Companies in this article

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

Abbott Labs

Read more about this company »